How high was Bristol-Myers Squibb stock in the last 52 weeks?

The high in the last 52 weeks of Bristol-Myers Squibb stock was 66.46. According to the current price, Bristol-Myers Squibb is 61.89% away from the 52-week high. What are analysts forecasts for Bristol-Myers Squibb stock?

Is Bristol-Myers Squibb stock a good buy?

Compared to the opening price on Friday 05/31/2024 on BTT of $40.42, this is a drop of 0.47%. Bristol-Myers Squibb Co.'s market capitalization is $81.79 B by 2.03 B shares outstanding. Is Bristol-Myers Squibb stock a Buy, Sell or Hold? Bristol-Myers Squibb stock has received a consensus rating of hold.

Is Bristol-Myers Squibb a US company?

Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group. Bristol-Myers Squibb is a leading worldwide biopharmaceutical company. Its products focus on oncology, immunology and cardiovascular conditions. The company completed its merger with Celgene in November 2019.

The World's Leading Crypto Trading Platform

Get my welcome gifts